Author

John P. Finnigan

Tisch Cancer InstituteORCID 0000-0003-3216-298XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Research Focus:software / tool· 1 Approach:statistical model· 1

Frequent Co-Authors

Nina BhardwajiD· 2 shared Alec Schrager· 1 shared Alex RubinsteyniD· 1 shared Andrei Ramirez-Valdez· 1 shared Andrew S. IshizukaiD· 1 shared Bülent Arman AksoyiD· 1 shared Christopher M. GarlissiD· 1 shared Daniel C. DouekiD· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Nina BhardwajORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyThe Journal of ImmunologyPeer-reviewedAug 29, 2026

Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres

Andrew S. Ishizuka, Christopher M. Garliss, Robert N. Goddu…·David R. Wilson

This study introduces oxidation-resistant (OXR) antigens by substituting cysteine and methionine with isosteres to improve peptide vaccine manufacturability without compromising immunogenicity.

DOI 10.1093/jimmun/vkag232

humanproteomics

𝕏 PostBluesky

BioinformaticsFrontiers in ImmunologyPeer-reviewedJan 18, 2018

Computational pipeline for the PGV-001 neoantigen vaccine trial

Alex Rubinsteyn, Julia Kodysh, Isaac Hodes…·Jeff Hammerbacher

The paper describes a computational pipeline for a personalized neoantigen vaccine trial, including tools for variant calling, peptide selection, and sequence reconstruction.

74 citations

humanwhole-exome sequencing

𝕏 PostBluesky